Mitsubishi UFJ Asset Management (UK)’s Supernus Pharmaceuticals SUPN Stock Holding History

Mitsubishi UFJ Asset Management (UK)’s Portfolio SUPN Stock Details SUPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-27,000	Closed	-$976K	–	125
2024 Q4	$976K	Buy	27,000 +3,000	+13%	+$106K	0.43%	60
2024 Q3	$748K	Hold	24,000	–	–	0.39%	80
2024 Q2	$642K	Hold	24,000	–	–	0.33%	73
2024 Q1	$819K	Hold	24,000	–	–	0.42%	62
2023 Q4	$695K	Hold	24,000	–	–	0.38%	70
2023 Q3	$662K	Sell	24,000 -10,000	-29%	-$304K	0.47%	67
2023 Q2	$1.02M	Buy	34,000 +2,000	+6%	+$70K	0.66%	52
2023 Q1	$1.16M	Sell	32,000 -11,000	-26%	-$423K	0.75%	52
2022 Q4	$1.53M	Hold	43,000	–	–	1.07%	36
2022 Q3	$1.46M	Hold	43,000	–	–	1.12%	34
2022 Q2	$1.24M	Hold	43,000	–	–	0.72%	48
2022 Q1	$1.39M	Hold	43,000	–	–	0.63%	60
2021 Q4	$1.25M	Buy	43,000 +8,000	+23%	+$243K	0.53%	63
2021 Q3	$933K	Buy	+35,000	New	+$939K	0.39%	76
2019 Q3	–	Sell	-22,500	Closed	-$745	–	82
2019 Q2	$745	Sell	22,500 -5,000	-18%	-$171K	0.01%	75
2019 Q1	$964	Hold	27,500	–	–	0.01%	59
2018 Q4	$914K	Buy	27,500 +10,000	+57%	+$430K	0.46%	64
2018 Q3	$881	Buy	17,500 +4,000	+30%	+$198K	0.02%	78
2018 Q2	$807K	Hold	13,500	–	–	0.46%	71
2018 Q1	$618K	Sell	13,500 -20,000	-60%	-$835K	0.41%	68
2017 Q4	$1.33M	Buy	+33,500	New	+$1.32M	0.96%	42

Other funds holding SUPN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Mitsubishi UFJ Asset Management (UK)'s SUPN Position: Q1 2025 in Review

Mitsubishi UFJ Asset Management (UK) sold out of Supernus Pharmaceuticals (SUPN) in Q1 2025, closing a stake of 27,000 shares — an estimated $976K sold.

Mitsubishi UFJ Asset Management (UK) first reported a position in SUPN in Q4 2017 and held it in 21 quarters. The position peaked at $1.53M in Q4 2022. 295 funds tracked by Wall St. Rank hold SUPN as of Q1 2025.

Mitsubishi UFJ Asset Management (UK) reported no remaining Supernus Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
Mitsubishi UFJ Asset Management (UK) sold 27,000 Supernus Pharmaceuticals shares in Q1 2025, an estimated $976K.
Mitsubishi UFJ Asset Management (UK) first reported a position in Supernus Pharmaceuticals in Q4 2017 and held it in 21 quarters.
Mitsubishi UFJ Asset Management (UK)'s Supernus Pharmaceuticals position peaked at $1.53M in Q4 2022.
295 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q1 2025.

Based on Mitsubishi UFJ Asset Management (UK)'s 13F filing for Q1 2025, filed 13 May 2025.